Actively Recruiting
Evaluating Remote Ischemic Conditioning Alongside Standard Treatment to Manage Essential Hypertension in Adults Aged 30 to 75
Led by Yi Yang · Updated on 2026-07-28
500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to investigate the efficacy and safety of remote ischemic conditioning RIC treatment for adults with essential hypertension living in community settings. Hypertension is a major controllable risk factor for stroke, which is a leading cause of death. RIC may help lower blood pressure by improving blood vessel function, reducing nervous system activity, and regulating immune responses. Participants are randomly assigned to one of two groups one group continues their previous antihypertensive treatment combined with remote ischemic conditioning, while the other group continues their previous antihypertensive treatment alone. The RIC procedure involves four cycles of 5 minutes of upper arm blood flow restriction followed by 5 minutes of reperfusion, induced by inflating a blood pressure cuff to 200 mmHg. During the approximately two-week study period, participants will have multiple blood pressure measurements to monitor changes in systolic and diastolic blood pressure and to assess how well blood pressure targets are met. Researchers will evaluate the main outcome of mean systolic blood pressure changes after 12 to 14 days. Safety and treatment effects will be monitored regularly throughout the trial, which is expected to complete by July 2026.
CONDITIONS
Brief Title
Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension
Research Team
Y
Yi Yang, MD,PhD
Z
Zhen-Ni Guo, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here